Gordon Joshua A, Hen Rene
Department of Psychiatry, Center for Neurobiology and Behavior, Columbia University, and the New York State Psychiatric Institute, NY, USA.
Neuromolecular Med. 2004;5(1):27-40. doi: 10.1385/NMM:5:1:027.
The wide use of serotonin reuptake inhibitors and serotonin receptor agonists in anxiety disorders has suggested a key role for the modulatory neurotransmitter in anxiety. However, serotonin's specific role is still uncertain. This article reviews the literature concerning how and where serotonergic agents modulate anxiety. Varying and sometimes conflicting data from human and animal studies argue for both anxiolytic and anxiogenic roles for serotonin, depending on the specific disorder, structure, or behavioral task studied. However, recent data from molecular genetic studies in the mouse point toward two important roles for the serotonin 1A receptor. In development, serotonin acts through this receptor to promote development of the circuitry necessary for normal anxiety-like behaviors. In adulthood, serotonin reuptake inhibitors act through the same receptor to stimulate neurogenesis and reduce anxiety-like behaviors. These studies highlight that the complex serotonin system likely plays various roles in the regulation of anxiety both during development and in adulthood.
血清素再摄取抑制剂和血清素受体激动剂在焦虑症中的广泛应用表明,这种调节性神经递质在焦虑中起关键作用。然而,血清素的具体作用仍不确定。本文综述了有关血清素能药物如何以及在何处调节焦虑的文献。来自人类和动物研究的数据各不相同,有时甚至相互矛盾,这表明血清素根据所研究的特定疾病、结构或行为任务,既具有抗焦虑作用,也具有致焦虑作用。然而,最近小鼠分子遗传学研究的数据表明血清素1A受体有两个重要作用。在发育过程中,血清素通过该受体促进正常焦虑样行为所需神经回路的发育。在成年期,血清素再摄取抑制剂通过同一受体刺激神经发生并减少焦虑样行为。这些研究强调,复杂的血清素系统可能在发育过程和成年期的焦虑调节中发挥多种作用。